Global KOL Influence Mapping: Latest Innovations to Measure Peer Influence
Sandra Shpilberg
Co-Founder & CEO @ Adnexi - To accelerate treatment development, Adnexi finds, profiles and engages the most influential health experts - using a lot of technology!
In biopharma, Key Opinion Leaders are thought to be those experts in the disease who have very significant scientific activity. At Adnexi, we track this activity, processing massive data on publications, clinical trials, NIH grants, payments from biopharma, speaking activity and more, and producing complete profiles.
However, just because a KOL has had a ton of scientific activity, does not mean that their peers find this person currently influential. And those KOLs that are most influential can significantly accelerate drug development and launch.
A new method was needed to prioritize KOLs, and this is why we developed Adnexi Influence Mapping, a solution to uncover the peer-to-peer influence of KOLs across the globe. With AIM we deploy a customized survey for the therapeutic area and collect and process nomination data. We can deploy the survey in a specific country or across the globe and for any therapeutic area.
Recently, we deployed the Adnexi Influence Mapping (AIM)?solution to help a rare disease treatment developer find the most influential Key Opinion Leaders in the diagnosis and treatment of this rare disease across the globe.?
These efforts transformed the launch targeting, enabling the confirmation of certain known KOLs and the identification of new and emerging community HCPs influencing the treatment of this disease.?This made the launch more targeted and efficient.?Our deliverables included a full platform with interactive maps and full HCP profiles + a presentation for the launch team.?
Please click here to watch our video case summary.?We're proud of our exclusive partnership with Sermo to execute this solution.
We would love to help other biopharma companies with this innovative approach.
If you're interested in learning more, please contact:
Sandra Shpilberg
Email: [email protected]
Book a meeting: https://calendly.com/adnexi/30min
On-Demand LifeSciences Advisor, Consultant and Strategic Partner. Generalizing Specialist. Leading Strategy to Implementation, with Metrics (as efficiently as possible). Certified Business Process Management
1 年Amazing that 75% were interested in engaging with the manufacturer/co. Great stuff.
Pharmaceutical Marketing Strategist
1 年I feel like the industry is not putting enough weight on a KOL’s social presence. If they have a following on social, it’s often a more valuable criteria than other attributes like speaking experience or publications. They bring an existing and trusted audience.
Drug Development Exec | Trusted Advisor | Clinical Strategist | Board Member | Builder | Patient Advocate | Explorer ?????? I take people, teams, and organizations further than they would otherwise go.
1 年Such an innovative and fantastic approach you've created!
Non-Executive Director | Board Director | CEO | Digital Transformation Expert | Corporate Strategist | Governance Leader | LegalTech & Risk Innovator | 6X TEDx Speaker | Author | IBDC.D | Made in Ukraine ????
1 年Great stuff! Thank you for sharing Sandra Shpilberg
Co-Founder & CEO @ Adnexi - To accelerate treatment development, Adnexi finds, profiles and engages the most influential health experts - using a lot of technology!
1 年Thomas Draime, MBA